Results 91 to 100 of about 11,227 (157)

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source

Comprehensive molecular docking and antifungal activity analysis of Moringa extracts targeting Candida auris dihydrofolate reductase (8CRH). [PDF]

Sci Rep
Wizrah MSI, Yahia ZA, Al-Omari H, Aldawsari ND, Alrokban AH, Alsugiran NI, Khalid A, Elsayim R.   +7 more
europepmc   +1 more source

Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM-ISHAM Working Group. [PDF]

Microorganisms
Gandolpho LS, Aguilar-Zapata D, Moncada-Vallejo PA, Riera F, Guaraná M, Breda GL, Rabagliati R, Nucci M, Colombo AL.   +8 more
europepmc   +1 more source

Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study. [PDF]

Open Forum Infect Dis
Hatzl S, Geiger C, Kriegl L, Reinisch A, Keldorfer M, Wölfler A, Wallner M, von Lewinski D, Eller P, Krause R.   +9 more
europepmc   +1 more source

Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice. [PDF]

Mycoses
Boán J, Aparicio-Minguijón E, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Rodríguez-Goncer I, López-Medrano F, San-Juan R, Silva JT, Pérez-Ayala A, Caro-Teller JM, Aguado JM.   +10 more
europepmc   +1 more source

A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches. [PDF]

Indian J Pharmacol
Gurajala S, Challapilla M.
europepmc   +1 more source

Candida glabrata Emerges as the Most Common Cause of Candidemia: Analysis of a Large Hospital-Based Database, United States, 2016-2024. [PDF]

Clin Infect Dis
Gold JAW, Benedict K, Lyman M, Toda M, Little JS, Ostrosky-Zeichner L.   +5 more
europepmc   +1 more source

Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonization. [PDF]

Antimicrob Agents Chemother
Arastehfar A, Daneshnia F, Hovhannisyan H, Cabrera N, Jusuf S, Salehi M, Mansour MK, Gabaldón T, Shor E, Perlin DS.   +9 more
europepmc   +1 more source

Yeast infections in sterile body fluids: species distribution, antifungal susceptibility, and cross-cutting risk factors for fungemia, sepsis, and mortality (2019-2023). [PDF]

Front Microbiol
Liu J, Han M, Yang F, Gao S, Zhou W, Shen H, Cao X, Zhang Y.   +7 more
europepmc   +1 more source

Emergence of multidrug-resistant <i>Candidozyma auris</i> in southern China: a multicenter study on genetic diversity and antifungal resistance. [PDF]

Front Microbiol
Guo P, Fang J, Wang R, Lin W, Jiang Y, Long J, Chen L, Huang X, Liao K, Peng Y.   +9 more
europepmc   +1 more source